Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07238478 · ClinicalTrials.gov registry record · NA
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
A NA study of Hot Flashes and Joint Pain, sponsored by Bonafide Health.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT07238478 is a NA study of Hot Flashes and Joint Pain that is actively recruiting participants, run by Bonafide Health. The registered enrollment target is 250 participants, above the 161-participant average among 23 other Hot Flashes trials with a reported enrollment target (55% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07238478, a NA study of Hot Flashes and Joint Pain, is actively recruiting participants, sponsored by Bonafide Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for 12 weeks can reduce the severity and frequency of menopause-related symptoms.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT JDS-HF3.0
Study Locations (1)
New York
- Bonafide Health - Harrison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07238478
The ClinicalTrials.gov registry entry for NCT07238478 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 161-participant average among 23 other Hot Flashes trials with a reported enrollment target (55% higher). The listed sponsor is Bonafide Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Hot Flashes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07238478 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07238478 about?
NCT07238478 is a clinical study titled "JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women". The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for...
What is the current status of trial NCT07238478?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-05-14. Estimated completion is 2026-10.
What conditions does trial NCT07238478 study?
This clinical trial studies the following conditions: Hot Flashes, Joint Pain, Vasomotor Symptoms, Night Sweats, Joint Discomfort.
What interventions are being tested in trial NCT07238478?
The interventions under investigation include: Placebo (OTHER), JDS-HF3.0 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07238478?
This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07238478 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hot Flashes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
RECRUITING · NA
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
COMPLETED · NA
-
Reducing the Experience of Menopausal Symptoms Through Temperature
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.